NO20091575L - Hoyenhets massetilberedning av stannsoporfin - Google Patents

Hoyenhets massetilberedning av stannsoporfin

Info

Publication number: NO20091575L
Authority: NO; Norway
Prior art keywords: porphine; stannous; unit mass; high unit; mass preparation
Prior art date: 2006-10-04

Application number

NO20091575A

Other languages

English (en)

Norwegian (no)

Inventor

Robert Caroselli

George S Drummond

Keith A Cooke

Daniel Levin

David G Roe

Christopher P Boucher

Original Assignee

Infacare Pharmaceutical Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-04

Filing date

2009-04-21

Publication date

2009-07-02

2009-04-21 Application filed by Infacare Pharmaceutical Corp filed Critical Infacare Pharmaceutical Corp

2009-07-02 Publication of NO20091575L publication Critical patent/NO20091575L/no

Links

JZRYQZJSTWVBBD-UHFFFAOYSA-N pentaporphyrin i Chemical compound N1C(C=C2NC(=CC3=NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 JZRYQZJSTWVBBD-UHFFFAOYSA-N 0.000 title 1
239000000203 mixture Substances 0.000 abstract 2
LLDZJTIZVZFNCM-UHFFFAOYSA-J 3-[18-(2-carboxyethyl)-8,13-diethyl-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid;dichlorotin(2+) Chemical compound [H+].[H+].[Cl-].[Cl-].[Sn+4].[N-]1C(C=C2C(=C(C)C(=CC=3C(=C(C)C(=C4)N=3)CC)[N-]2)CCC([O-])=O)=C(CCC([O-])=O)C(C)=C1C=C1C(C)=C(CC)C4=N1 LLDZJTIZVZFNCM-UHFFFAOYSA-J 0.000 abstract 1
229950001307 stannsoporfin Drugs 0.000 abstract 1
230000002194 synthesizing effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/22—Tin compounds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/22—Tin compounds
- C07F7/2284—Compounds with one or more Sn-N linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/003—Compounds containing elements of Groups 4 or 14 of the Periodic Table without C-Metal linkages

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Hematology (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Steroid Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Catalysts (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Medicinal Preparation (AREA)
Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20091575A 2006-10-04 2009-04-21 Hoyenhets massetilberedning av stannsoporfin NO20091575L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US84964106P	2006-10-04	2006-10-04
US90460107P	2007-02-28	2007-02-28
PCT/US2007/021485 WO2008045377A2 (fr)	2006-10-04	2007-10-04	Préparation de stannsoporfine de grande pureté produite en grande quantité

Publications (1)

Publication Number	Publication Date
NO20091575L true NO20091575L (no)	2009-07-02

Family

ID=39144566

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20091575A NO20091575L (no)	2006-10-04	2009-04-21	Hoyenhets massetilberedning av stannsoporfin

Country Status (22)

Country	Link
US (9)	US7960371B2 (fr)
EP (3)	EP2384756B1 (fr)
JP (2)	JP5524622B2 (fr)
KR (5)	KR20140023447A (fr)
CN (2)	CN104116745B (fr)
AT (1)	ATE524187T1 (fr)
AU (1)	AU2007307111B2 (fr)
BR (1)	BRPI0717775B8 (fr)
CA (1)	CA2665075C (fr)
CY (1)	CY1114562T1 (fr)
DK (1)	DK2079472T3 (fr)
EA (2)	EA030262B1 (fr)
ES (1)	ES2556359T3 (fr)
HR (1)	HRP20110746T1 (fr)
IL (4)	IL197838A (fr)
MX (2)	MX2009003530A (fr)
NO (1)	NO20091575L (fr)
NZ (4)	NZ599321A (fr)
PL (1)	PL2079472T3 (fr)
PT (1)	PT2079472E (fr)
RS (1)	RS52185B (fr)
WO (1)	WO2008045377A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7375216B2 (en)	2002-06-04	2008-05-20	Infacare Pharmaceutical Corporation	Preparation of metal mesoporphyrin compounds
US20060222668A1 (en) *	2005-04-01	2006-10-05	Wellspring Pharmaceutical Corporation	Stannsoporfin compositions, drug products and methods of manufacture
KR20140023447A (ko)	2006-10-04	2014-02-26	인파케어 파마슈티칼 코포레이션	스탄소포르핀의 고순도 대규모 제조법
ES2609110T3 (es)	2011-03-30	2017-04-18	Infacare Pharmaceutical Corporation	Procedimientos de síntesis de mesoporfirinas metálicas
CA2857153A1 (fr) *	2011-12-01	2013-06-06	Infacare Pharmaceutical Corporation	Methodes d'utilisation de la mesoporphyrine d'etain pour le traitement de l'hyperbilirubinemie
CN103214491B (zh) *	2013-03-13	2016-01-20	南京理工大学	[2,7,12,18-四甲基-3,8-二乙基-13,17-二羧基乙基]-卟啉的制备方法
EP3200582B1 (fr)	2014-09-29	2023-11-15	Fred Hutchinson Cancer Center	Compositions, kits et procédés pour induire une cytorésistance acquise à l'aide d'inducteurs de protéines du stress
HUE063182T2 (hu)	2019-02-28	2024-01-28	Renibus Therapeutics Inc	Újszerû vaskészítmények és elõállítási és felhasználási eljárásaik
KR20230084522A (ko) *	2020-10-02	2023-06-13	아드게로 바이오파마슈티컬스 홀딩스, 인코포레이티드	니켈(ii) 에티오포르피린-i의 제조 방법
WO2025165353A1 (fr) *	2024-01-31	2025-08-07	Renibus Therapeutics, Inc.	Nouvelles compositions de protoporphyrine stannique, leurs procédés de fabrication et leurs utilisations

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS58501130A (ja)	1981-07-15	1983-07-14	ザ　ロツクフエラ−　ユニバ−シテイ	ヘムの代謝速度の低下方法
US4684637A (en)	1981-07-15	1987-08-04	The Rockefeller University	Method of decreasing rate of heme metabolism
US4708964A (en)	1984-02-09	1987-11-24	Chemex Pharmaceuticals	Lipoxygenase inhibitors
AU570143B2 (en)	1985-01-14	1988-03-03	Rockefeller University, The	Method of increasing heme excretion from a mammal using tin protoporphyrin
US4619923A (en)	1985-01-14	1986-10-28	The Rockefeller University	Metal protoporphyrins in the control of tryptophan metabolism
US4657902A (en)	1985-03-25	1987-04-14	The Rockefeller University	Therapeutic use of tin mesoporphyrin
US4692440A (en)	1985-03-25	1987-09-08	The Rockefeller University	Therapeutic use of tin mesoporphyrin
US4692439A (en)	1986-06-20	1987-09-08	The Rockefeller University	Therapeutic use of tin diiododeuteroporphyrin
US4668670A (en)	1986-06-20	1987-05-26	The Rockefeller University	Tin diiododeuteroporphyrin and therapeutic use thereof
US4861876A (en)	1986-11-26	1989-08-29	Wayne State University	Hematoporphyrin derivative and method of preparation and purification
US4782049A (en)	1986-12-08	1988-11-01	The Rockefeller University	Tin protoporphyrin and tin mesoporphyrin in the treatment of psoriasis
US4900871A (en)	1987-01-02	1990-02-13	Sun Refining And Marketing Company	Hydrocarbon oxidations catalyzed by iron coordination complexes containing a halogenated ligand
US5990363A (en)	1987-01-02	1999-11-23	Sun Company, Inc.	Method for oxidizing alkanes using novel porphyrins synthesized from dipyrromethanes and aldehydes
WO1989002269A1 (fr)	1987-09-08	1989-03-23	The Rockefeller University	Utilisation de metalloporphyrines afin d'inverser l'effet toxique de la therapie de tumeurs
US5081115A (en)	1987-10-15	1992-01-14	The Board Of Trustees Of The Leland Stanford Junior University	Method to prevent neonatal jaundice with metalloporphyrin compositions
US4831024A (en)	1987-10-15	1989-05-16	The Board Of Trustees Of The Leland Stanford Junior University	Method to prevent neonatal jaundice
DE3827940A1 (de)	1988-08-13	1990-03-01	Schering Ag	13,17-propionsaeure- und propionsaeurederivat- substituierte porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5162313A (en)	1989-03-16	1992-11-10	The Rockefeller University	Control of heme and iron concentrations in body tissues
US5223494A (en)	1989-09-25	1993-06-29	The Rockefeller University	Orally administered porphyrins to control intestinal iron absorption
US5062775A (en)	1989-09-29	1991-11-05	Rocky Mountain Research, Inc.	Roller pump in an extra corporeal support system
US5010073A (en)	1989-10-05	1991-04-23	The Rockefeller University	Use of liposomes as carriers for metalloporphyrins
US5192757A (en)	1990-12-20	1993-03-09	Glaxo Inc.	Cobalt porphyrins
EP0527016A1 (fr)	1991-08-01	1993-02-10	E.I. Du Pont De Nemours And Company	Quinoxalinyloxyéthers herbicides
US5493017A (en)	1992-08-14	1996-02-20	The Trustees Of The University Of Pennsylvania	Ring-metalated porphyrins
US5817830A (en)	1992-08-14	1998-10-06	Trustees Of The University Of Pennsylvania	Pyrrolic compounds
US5371199B1 (en) *	1992-08-14	1995-12-26	Univ Pennsylvania	Substituted porphyrins porphyrin-containing polymers and synthetic methods therefor
IL108241A (en) *	1992-12-30	2000-08-13	Biosource Genetics Corp	Plant expression system comprising a defective tobamovirus replicon integrated into the plant chromosome and a helper virus
AU7103594A (en)	1993-06-14	1995-01-03	Rockefeller University, The	Treatment of neonatal hyperbilirubin with metalloporphyrin
US5665869A (en) *	1993-11-15	1997-09-09	Somatogen, Inc.	Method for the rapid removal of protoporphyrin from protoporphyrin IX-containing solutions of hemoglobin
CA2130853A1 (fr)	1994-08-25	1996-02-26	Svetlana Kudrevich	Methode de synthese de phtalocyanines, de naphtobenzoporphyrazines et de porphyrines monosulfonees, par reaction modifiee de meerwein
US6066333A (en)	1994-09-22	2000-05-23	William Harvey Research Limited	Pharmaceutical control of inflammation
US5912341A (en)	1995-03-14	1999-06-15	Hoffman/Barrett, L.L.C.	Heteroatom-functionalized porphyrazines and multimetallic complexes and polymers derived therefrom
AU6497996A (en)	1995-08-02	1997-02-26	Warner-Lambert Company	Amino acid complexes of cobalt (iii) mesoporphyrin ix and cobalt (iii) protoporphyrin ix
US5883246A (en)	1996-03-07	1999-03-16	Qlt Phototherapeutics, Inc.	Synthesis of polypyrrolic macrocycles from meso-substituted tripyrrane compounds
US6004530A (en)	1996-06-04	1999-12-21	Roche Diagnostics Gmbh	Use of metallo-porphyrin conjugates for the detection of biological substances
GB9616353D0 (en)	1996-08-03	1996-09-11	Secr Defence	Metallo-porphyrins
US6124452A (en)	1997-12-19	2000-09-26	University Of Nebraska-Lincoln	Octafluoro-meso-tetraarylporphyrins and methods for making these compounds
DE19706490C1 (de)	1997-02-19	1998-09-17	Deutsches Krebsforsch	Verfahren zur Herstellung von Säureamiden und zur Metallierung von Verbindungen und Verwendung der nach den Verfahren hergestellten Verbindungen
US5886173A (en)	1997-07-30	1999-03-23	Pharmacyclics, Inc.	Metallation of macrocycles with 2,4-dicarbonyl-metal complexes
US6194566B1 (en)	1997-12-02	2001-02-27	Schering Aktiengesellschaft	Process for the production of metalloporphyrin-metal complex conjugates
JP3673888B2 (ja)	1998-03-09	2005-07-20	独立行政法人科学技術振興機構	ポルフィリン類金属錯体の製造方法
DE19831217A1 (de)	1998-07-03	2000-01-05	Schering Ag	Neue Porphyrinderivate, diese enthaltende pharmazeutische Mittel und ihre Verwendung in der photodynamischen Therapie und MRI-Diagnostik
US5973141A (en)	1998-11-27	1999-10-26	Miravant Pharmaceuticals, Inc.	Method for the demethoxycarbonylation of porphyrinic compounds such as pheophorbides
EP1261346A4 (fr)	2000-03-10	2004-10-13	Univ Rockefeller	Modulation de lesion cardio-vasculaire
US6462192B2 (en) *	2001-01-23	2002-10-08	Miravant Pharmaceuticals, Inc.	Processes for large scale production of tetrapyrroles
US7020531B1 (en) *	2001-05-01	2006-03-28	Intrapace, Inc.	Gastric device and suction assisted method for implanting a device on a stomach wall
CA2448570A1 (fr)	2001-05-31	2002-12-05	Miravant Pharmaceuticals, Inc.	Derives porphyrine et azaporphyrine substitues et utilisation en therapie photodynamique, radioimagerie, et diagnostic par irm
EP1509527B1 (fr) *	2002-06-04	2014-05-07	InfaCare Pharmaceutical Corporation	Preparation de composes d'halogenure metallique de mesoporphyrine
US7375216B2 (en)	2002-06-04	2008-05-20	Infacare Pharmaceutical Corporation	Preparation of metal mesoporphyrin compounds
US7157401B2 (en) *	2002-10-17	2007-01-02	Carnegie Mellon University	Catalyst for the treatment of organic compounds
US20040097481A1 (en)	2002-11-20	2004-05-20	Benjamin Levinson	Water-soluble mesoporphyrin compounds and methods of preparation
DE602004019761D1 (de) *	2003-01-08	2009-04-16	Novartis Vaccines & Diagnostic	Stabilisierte wässrige zusammensetzungen mit gewebefaktorinhibitor (tfpi) oder gewebefaktorinhibitor-variante
US20050247320A1 (en) *	2003-10-10	2005-11-10	Stack Richard S	Devices and methods for retaining a gastro-esophageal implant
NL1025049C2 (nl) *	2003-12-18	2005-06-21	Photobiochem N V	Werkwijze voor de bereiding van porfyrinederivaten.
AU2006232330A1 (en)	2005-04-01	2006-10-12	Infacare Pharmaceutical Corporation	Stannsoporfin compositions and administration
US20060222668A1 (en)	2005-04-01	2006-10-05	Wellspring Pharmaceutical Corporation	Stannsoporfin compositions, drug products and methods of manufacture
AU2012202684B2 (en)	2006-10-04	2014-04-10	Mallinckrodt Hospital Products IP Limited	High-purity large-scale preparation of stannsoporfin
UA99904C2 (ru)	2006-10-04	2012-10-25	Инфакеар Фармасьютикал Корпорейшн	Производство станнсопорфина высокой чистоты
KR20140023447A (ko)	2006-10-04	2014-02-26	인파케어 파마슈티칼 코포레이션	스탄소포르핀의 고순도 대규모 제조법
CA2664934A1 (fr)	2006-10-04	2008-04-17	Infacare Pharmaceutical Corporation	Traitement d'hyperbilirubinemie infantile en utilisant des faibles dosages de stannsoporfine
FR2914302A1 (fr) *	2007-03-30	2008-10-03	Sanofi Pasteur Sa	Procede de preparation de derives de porphyrine, telle que la protoporphyrine (ix) et intermediaire de synthese
ES2609110T3 (es)	2011-03-30	2017-04-18	Infacare Pharmaceutical Corporation	Procedimientos de síntesis de mesoporfirinas metálicas
CA2857153A1 (fr)	2011-12-01	2013-06-06	Infacare Pharmaceutical Corporation	Methodes d'utilisation de la mesoporphyrine d'etain pour le traitement de l'hyperbilirubinemie
US9635905B2 (en)	2012-12-10	2017-05-02	Nike, Inc.	Upper having bonded differentially-oriented inner and outer reinforcing strips

2007
- 2007-10-04 KR KR1020147002613A patent/KR20140023447A/ko not_active Ceased
- 2007-10-04 KR KR1020127032529A patent/KR101400714B1/ko not_active Expired - Fee Related
- 2007-10-04 CN CN201410188263.XA patent/CN104116745B/zh not_active Expired - Fee Related
- 2007-10-04 WO PCT/US2007/021485 patent/WO2008045377A2/fr not_active Ceased
- 2007-10-04 DK DK07839341.0T patent/DK2079472T3/da active
- 2007-10-04 EP EP11176115.1A patent/EP2384756B1/fr not_active Not-in-force
- 2007-10-04 BR BRPI0717775A patent/BRPI0717775B8/pt not_active IP Right Cessation
- 2007-10-04 AT AT07839341T patent/ATE524187T1/de active
- 2007-10-04 NZ NZ599321A patent/NZ599321A/xx not_active IP Right Cessation
- 2007-10-04 KR KR1020097008733A patent/KR101253541B1/ko not_active Expired - Fee Related
- 2007-10-04 NZ NZ703991A patent/NZ703991A/en not_active IP Right Cessation
- 2007-10-04 MX MX2009003530A patent/MX2009003530A/es active IP Right Grant
- 2007-10-04 NZ NZ576030A patent/NZ576030A/en not_active IP Right Cessation
- 2007-10-04 US US11/867,559 patent/US7960371B2/en active Active
- 2007-10-04 NZ NZ61567307A patent/NZ615673A/en not_active IP Right Cessation
- 2007-10-04 AU AU2007307111A patent/AU2007307111B2/en not_active Ceased
- 2007-10-04 RS RS20110455A patent/RS52185B/sr unknown
- 2007-10-04 HR HR20110746T patent/HRP20110746T1/hr unknown
- 2007-10-04 JP JP2009531482A patent/JP5524622B2/ja not_active Expired - Fee Related
- 2007-10-04 PL PL07839341T patent/PL2079472T3/pl unknown
- 2007-10-04 PT PT07839341T patent/PT2079472E/pt unknown
- 2007-10-04 EA EA201400124A patent/EA030262B1/ru not_active IP Right Cessation
- 2007-10-04 CN CN200780043624.XA patent/CN101573122B/zh not_active Expired - Fee Related
- 2007-10-04 KR KR1020157033361A patent/KR20150138415A/ko not_active Ceased
- 2007-10-04 KR KR1020147023615A patent/KR101573013B1/ko not_active Expired - Fee Related
- 2007-10-04 EP EP15185138.3A patent/EP2992886A1/fr not_active Withdrawn
- 2007-10-04 MX MX2011007519A patent/MX345035B/es unknown
- 2007-10-04 EP EP07839341A patent/EP2079472B1/fr active Active
- 2007-10-04 EA EA200970344A patent/EA019864B1/ru unknown
- 2007-10-04 CA CA2665075A patent/CA2665075C/fr active Active
- 2007-10-04 ES ES11176115.1T patent/ES2556359T3/es active Active
2009
- 2009-03-26 IL IL197838A patent/IL197838A/en active IP Right Grant
- 2009-04-21 NO NO20091575A patent/NO20091575L/no not_active Application Discontinuation
2010
- 2010-12-15 US US12/968,651 patent/US8530458B2/en not_active Expired - Fee Related
2011
- 2011-10-07 CY CY20111100961T patent/CY1114562T1/el unknown
- 2011-10-27 IL IL215978A patent/IL215978A/en active IP Right Grant
2013
- 2013-09-05 US US14/019,513 patent/US8835416B2/en active Active
- 2013-11-08 JP JP2013232129A patent/JP6195367B2/ja not_active Expired - Fee Related
2014
- 2014-08-14 US US14/460,080 patent/US9107927B2/en not_active Expired - Fee Related
2015
- 2015-07-08 US US14/793,921 patent/US9517239B2/en not_active Expired - Fee Related
2016
- 2016-10-27 IL IL248539A patent/IL248539A0/en unknown
- 2016-11-04 US US15/343,967 patent/US9902745B2/en not_active Expired - Fee Related
2018
- 2018-01-11 US US15/867,900 patent/US10273255B2/en active Active
2019
- 2019-03-11 US US16/298,603 patent/US10662209B2/en not_active Expired - Fee Related
- 2019-04-10 IL IL265947A patent/IL265947A/en unknown
2020
- 2020-05-01 US US16/864,510 patent/US11078220B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NZ703991A (en)	2016-07-29
EP2384756B1 (fr)	2015-09-16
RS52185B (sr)	2012-10-31
US8530458B2 (en)	2013-09-10
EP2079472A2 (fr)	2009-07-22
KR101573013B1 (ko)	2015-12-04
US10662209B2 (en)	2020-05-26
HK1132191A1 (en)	2010-02-19
NZ599321A (en)	2013-09-27
NZ576030A (en)	2012-06-29
US20200255458A1 (en)	2020-08-13
CA2665075A1 (fr)	2008-04-17
PL2079472T3 (pl)	2012-01-31
BRPI0717775B8 (pt)	2021-05-25
KR20140114894A (ko)	2014-09-29
KR20150138415A (ko)	2015-12-09
US20160000802A1 (en)	2016-01-07
WO2008045377A2 (fr)	2008-04-17
IL197838A (en)	2016-11-30
US8835416B2 (en)	2014-09-16
AU2007307111B2 (en)	2012-03-08
IL197838A0 (en)	2009-12-24
KR101253541B1 (ko)	2013-04-15
CN104116745A (zh)	2014-10-29
BRPI0717775B1 (pt)	2020-10-13
ES2556359T3 (es)	2016-01-15
HK1162939A1 (en)	2012-09-07
EP2384756A2 (fr)	2011-11-09
JP5524622B2 (ja)	2014-06-18
IL265947A (en)	2019-05-30
US20080125585A1 (en)	2008-05-29
CA2665075C (fr)	2014-03-18
ATE524187T1 (de)	2011-09-15
EA201400124A1 (ru)	2015-01-30
MX345035B (es)	2017-01-16
EP2079472B1 (fr)	2011-09-14
EP2384756A3 (fr)	2012-02-22
JP2010505853A (ja)	2010-02-25
JP6195367B2 (ja)	2017-09-13
US11078220B2 (en)	2021-08-03
US20140005380A1 (en)	2014-01-02
US20170073362A1 (en)	2017-03-16
US7960371B2 (en)	2011-06-14
AU2007307111A1 (en)	2008-04-17
CN101573122A (zh)	2009-11-04
WO2008045377A3 (fr)	2008-06-05
US9107927B2 (en)	2015-08-18
IL215978A (en)	2017-08-31
US10273255B2 (en)	2019-04-30
EA019864B1 (ru)	2014-06-30
US20150051184A1 (en)	2015-02-19
IL248539A0 (en)	2016-12-29
EP2992886A1 (fr)	2016-03-09
US9517239B2 (en)	2016-12-13
KR20090079219A (ko)	2009-07-21
KR20130010026A (ko)	2013-01-24
EA200970344A1 (ru)	2009-10-30
MX2009003530A (es)	2009-06-26
US20190202846A1 (en)	2019-07-04
CY1114562T1 (el)	2016-10-05
KR20140023447A (ko)	2014-02-26
KR101400714B1 (ko)	2014-05-30
US20110082292A1 (en)	2011-04-07
US9902745B2 (en)	2018-02-27
US20180134735A1 (en)	2018-05-17
HRP20110746T1 (hr)	2011-11-30
PT2079472E (pt)	2011-11-24
CN101573122B (zh)	2016-08-03
NZ615673A (en)	2015-03-27
CN104116745B (zh)	2018-07-06
BRPI0717775A2 (pt)	2014-04-29
DK2079472T3 (da)	2011-10-31
EA030262B1 (ru)	2018-07-31
IL215978A0 (en)	2011-12-29
JP2014193839A (ja)	2014-10-09

Legal Events

Date	Code	Title	Description
2022-05-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20091575L (no)	2009-07-02	Hoyenhets massetilberedning av stannsoporfin
MX2008010481A (es)	2008-12-19	Compuestos que tienen afinado para el receptor f-ht6.
MX2011011661A (es)	2011-11-18	Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750.
MX343042B (es)	2016-10-21	Compuestos heteroarilicos biciclicos.
WO2008005877A3 (fr)	2008-03-27	Inhibiteurs de c-kit et leurs utilisations
MX2009005462A (es)	2009-08-28	Analogos de 7,8-saturados-4,5-epoxi-morfinano.
WO2009135646A3 (fr)	2011-03-17	Compositions pharmaceutiques stables et procédés de préparation desdites compositions adaptés à l’échelle industrielle
WO2007125103A3 (fr)	2008-04-10	Activateurs de la glucokinase benzamidique
BRPI0814531A2 (pt)	2015-08-04	Processo de preparo de composições pulverulentas estáveis
GB0517092D0 (en)	2005-09-28	New compositions containing taxane derivatives
CR11157A (es)	2010-03-23	Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica
EP2129672A4 (fr)	2009-12-09	Dérivés ester et carbamate d'azaadamantane et leurs procédés d'utilisation
MX2009012471A (es)	2010-02-24	Compuestos 4´sustituidos que tienen afinidad al receptor 5-hidroxitriptamina 6.
MX2009008028A (es)	2009-08-07	Agentes antiparasitarios.
MX2009006750A (es)	2009-06-30	Derivados de azaadamantano espirociclicos y metodos de uso.
JO2770B1 (en)	2014-03-15	Organic compounds
TW200740814A (en)	2007-11-01	Compounds
EA201000703A1 (ru)	2010-12-30	Производные пиразола в качестве ингибиторов 5-lo
MX2009010176A (es)	2009-10-12	Derivados de aza-adamantano 4-substituidos y metodos de uso de los mismos.
CY1110944T1 (el)	2015-06-10	Νεα παραγωγα κυκλοαλκυλιωμενων βενζοθειαδιαζινων, μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν
GEP20094745B (en)	2009-07-27	Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same
UA99904C2 (ru)	2012-10-25	Производство станнсопорфина высокой чистоты
GEP20094744B (en)	2009-07-27	Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same
WO2011057192A3 (fr)	2011-09-29	Compositions amphiphiles et procédés de préparation utilisant celles-ci
WO2006082598A3 (fr)	2006-10-19	Nouvelles formes cristallines de rizatriptane benzoate